EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure–Activity Relationship Studies of Tetracyclic Pyrrolocarbazoles Inhibiting Heterotetrameric Protein Kinase CK2

Lukas Kröger, Sebastian Borgert iD, Miriam Lauwers iD, Michaela Steinkrüger, Joachim Jose iD, Markus Pietsch iD, Bernhard Wünsch iD

Molecules · 2024

DOI: 10.3390/molecules30010063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Lukas Kröger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Pharmazeutische und Medizinische Chemie, Universität Münster, Corrensstraße 48, D-48149 Münster, Germany. Hauptthemen laut MEDLINE: Casein Kinase II, Carbazoles, Protein Kinase Inhibitors. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, discount voucher ba8c87d23218af92 (100.00%).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The serine/threonine kinase CK2 (formerly known as casein kinase II) plays a crucial role in various CNS disorders and is highly expressed in various types of cancer. Therefore, inhibiting this key kinase could be promising for the treatment of these diseases. The CK2 holoenzyme is formed by the recruitment of two catalytically active CK2α and/or CK2α′ subunits by a regulatory CK2β dimer. Starting with the lead furocarbazole W16 (4) inhibiting the CK2α/CK2β interaction, analogous pyrrolocarbazoles were prepared and tested for their protein–protein interaction inhibition (PPII). The key step of the synthesis was a multicomponent Levy reaction of 2-(indolyl)acetate 6, benzaldehydes 7, and N-substituted maleimides 8. Targeted modifications were performed by the saponification of the tetracyclic ester 9a, followed by the coupling of the resulting acid 10 with diverse amines. The replacement of the O-atom of the lead furocarbazole 4 by an N-atom in pyrrolocarbazoles retained or even increased the inhibition of the CK2α/CK2β interaction. The large benzyloxazolidinyl moiety of 4 could be replaced by smaller N-substituents without the loss of the PPII. The introduction of larger substituents at the 2-position and/or at p-position of the phenyl moiety at the 10-position to increase the surface for the inhibition of the PPI did not enhance the inhibition of the CK2α/CK2β association. The strong inhibition of the CK2α/CK2β association by the histidine derivative (+)-20a (Ki = 6.1 µM) translated into a high inhibition of the kinase activity of the CK2 holoenzyme (CK2α2β2, IC50 = 2.5 µM). Thus, 20a represents a novel lead compound inhibiting CK2 via the inhibition of the association of the CK2α and Ck2β subunits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Casein Kinase IICarbazolesProtein Kinase InhibitorsStructure-Activity RelationshipHumansProtein BindingMolecular StructureProtein Multimerization

Stichwörter der Autor:innen

CK2Levy reactioncapillary electrophoresisenzyme inhibitionheterotetrameric enzymemicroscale thermophoresisprotein kinaseprotein–protein interactionstereochemistrystructure–activity relationshipssurface enlargement

Substanzen

Casein Kinase IICarbazolesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Institut für Pharmazeutische und Medizinische Chemie, Universität Münster, Corrensstraße 48, D-48149 Münster, Germany.
  • Institutes I & II of Pharmacology, Center of Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Gleueler Straße 24, D-50931 Cologne, Germany.
  • Faculty of Applied Natural Sciences, TH Köln-University of Applied Sciences, Campus Leverkusen, Campusplatz 1, D-51379 Leverkusen, Germany.

ORCID-Profile: Sebastian Borgert, Miriam Lauwers, Joachim Jose, Markus Pietsch, Bernhard Wünsch

Förderung

  • Deutsche Forschungsgemeinschaft
  • discount voucher ba8c87d23218af92 (100.00%)

Zitieren

APA

Kröger, L., Borgert, S., Lauwers, M., Steinkrüger, M., Jose, J., Pietsch, M., & Wünsch, B. (2024). Structure–Activity Relationship Studies of Tetracyclic Pyrrolocarbazoles Inhibiting Heterotetrameric Protein Kinase CK2. Molecules. https://doi.org/10.3390/molecules30010063

Vancouver

Kröger L, Borgert S, Lauwers M, Steinkrüger M, Jose J, Pietsch M, et al. Structure–Activity Relationship Studies of Tetracyclic Pyrrolocarbazoles Inhibiting Heterotetrameric Protein Kinase CK2. Molecules. 2024. doi:10.3390/molecules30010063

BibTeX
@article{Krger2024,
  author = {Kröger, Lukas and Borgert, Sebastian and Lauwers, Miriam and Steinkrüger, Michaela and Jose, Joachim and Pietsch, Markus and Wünsch, Bernhard},
  title = {Structure–Activity Relationship Studies of Tetracyclic Pyrrolocarbazoles Inhibiting Heterotetrameric Protein Kinase CK2},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules30010063}
}
Kostenlos starten →